According to the report the trend is for pharma companies to engage contract research organizations (CRO) and contract development and manufacturing organizations (CDMO) as well as other suppliers “to cover nearly every aspect of drug development from target identification to clinical-trial execution.”
Better efficiency and, importantly for our audience, improved
Free Trial
Register for free to keep reading.
To continue reading this article and unlock full access to GRIP, register now. You’ll enjoy free access to all content until our subscription service launches in early 2026.
- Unlimited access to industry insights
- Stay on top of key rules and regulatory changes with our Rules Navigator
- Ad-free experience with no distractions
- Regular podcasts from trusted external experts
- Fresh compliance and regulatory content every day
